Last reviewed · How we verify

NCT06343389

Acute Kidney Injury in Patients With Liver Cirrhosis

Completed Last updated 15 April 2026
What this trial tests

trial testing serum creatinine in Acute Kidney Injury in Patients With Liver Cirrhosis in 180 participants. Completed in 15 July 2025.

Timeline
6 July 2024
Primary endpoint
15 October 2024
15 July 2025

Quick facts

Lead sponsorSohag University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment180
Start date6 July 2024
Primary completion15 October 2024
Estimated completion15 July 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

18 and older, any sex, with Acute Kidney Injury in Patients With Liver Cirrhosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In our locality, limited studies have discussed AKI in patients with liver cirrhosis and its outcome, therefore we aim to highlight the incidence, patterns, risk factors, and outcomes of acute kidney injury in patients with liver cirrhosis at Sohag University Hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of serum creatinine

Trials testing the same drug.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06343389.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing